Document ID: Z_2_07
Section: Molecular Biology & Genomics
Keywords: disease resistance, natural selection, pathogen-driven selection, sickle cell, malaria resistance, HbS, CCR5-delta32, HIV resistance, G6PD deficiency, Duffy antigen, thalassemia, balancing selection, heterozygote advantage, DARC, HLA diversity, innate immunity, TLR, interferons, plague, tuberculosis resistance, FUT2, cystic fibrosis carrier advantage
Category Tags: genetics, human-origins, evolution, medicine-healing
Cross-References: Z_2_11 — Genetics of Immunity MHC · Z_3_03 — Human Migration Genetics · L_2_02 — Population Genetics · ZB_2_01 — Natural Selection Evidence · Z_3_01 — Ancient DNA
Reliability Tier: Tier 1-2 (well-established genetic mechanisms; some evolutionary histories under active research)
Last Updated: Mar 7, 2026 | Source Count: 10 | Weighted Score: 30 | Source Confidence: [4/5] | Confidence: High

QUICK SUMMARY

Infectious disease has been the most powerful selective force shaping the human genome, leaving signatures across thousands of loci. The best-understood example is sickle cell disease (HbS, Glu6Val in HBB): heterozygous carriers have ~90% reduced risk of severe Plasmodium falciparum malaria — heterozygote advantage (balanced polymorphism) — explaining why a lethal recessive allele reaches frequencies of 10–20% in malaria-endemic regions of sub-Saharan Africa, the Mediterranean, and South Asia (Allison, 1954; Piel et al., 2010). Other malaria-resistance variants include G6PD deficiency (X-linked; ~400 million carriers globally — reduces parasite growth in red blood cells), Duffy-negative blood group (DARC/FY null, Fy^a-b-; near-fixation in West/Central Africa — eliminates the receptor for P. vivax invasion), alpha- and beta-thalassemia (reduced hemoglobin chain synthesis; HbF persistence and altered red cell properties impair parasite development), and Southeast Asian ovalocytosis (SLC4A1 27-bp deletion — rigid red cell membrane resists P. falciparum entry). Beyond malaria: CCR5-Δ32 (32-bp deletion in the HIV co-receptor CCR5; homozygous individuals are highly resistant to R5-tropic HIV-1; frequency ~10% in Northern Europeans, essentially absent in Africans and East Asians; the selective agent for its historical rise remains debated — originally attributed to plague/Yersinia pestis, now proposed as smallpox or other pathogen). HLA/MHC diversity (Z_2_11) is the most polymorphic region in the genome, maintained by pathogen-driven balancing selection — populations with greater HLA diversity resist a broader range of pathogens. FUT2 (secretor status, Lewis blood group) non-secretor homozygotes are resistant to norovirus; IFITM3 variants affect influenza severity; TLR variants modulate innate immune responses. Ancient DNA has revealed that plague-associated loci (ERAP2, CTLA4, TICAM2) underwent strong selection during the Black Death (~1346–1353 CE; Klunk et al., 2022, Nature). The study of disease-resistance genetics reveals that human genetic diversity is not random — it is substantially shaped by millennia of human-pathogen coevolution.

1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)

1.1 Sickle Cell and Malaria

• HbS (Glu6Val): Single nucleotide change in HBB (beta-globin gene, chromosome 11p15.4); HbS polymerizes under low oxygen → sickle-shaped red blood cells → vaso-occlusive crises, hemolytic anemia in homozygotes (sickle cell disease); heterozygotes (sickle cell trait, HbAS) are phenotypically near-normal under most conditions
• Malaria protection mechanism: HbAS carriers show ~90% reduction in severe P. falciparum malaria and ~70% reduction in clinical malaria (Ackerman et al., 2005); mechanisms include: (1) enhanced sickling of parasitized red cells → accelerated splenic clearance, (2) reduced parasite growth in HbAS erythrocytes, (3) enhanced innate immune recognition of infected cells, (4) reduced cytoadherence of parasitized cells to endothelium
• Geographic correlation: HbS frequency precisely mirrors historical P. falciparum malaria endemicity — highest in tropical Africa (10–20%), present in Mediterranean, Middle East, India; absent in malaria-free regions; confirmed by Haldane's "malaria hypothesis" (1949) and Allison's field data from East Africa (1954)
• Multiple independent origins: HbS arose at least 5 times independently on different haplotype backgrounds (Senegal, Benin, Bantu, Cameroon, Arab-Indian haplotypes) — convergent evolution demonstrating the strength of malaria selection

1.2 Other Malaria Resistance Variants

1.3 CCR5-Δ32 and HIV Resistance

• CCR5 (C-C chemokine receptor 5): Co-receptor used by R5-tropic HIV-1 to enter CD4+ T cells; a 32-bp deletion (Δ32) produces a non-functional truncated protein that cannot reach the cell surface
• Homozygous CCR5-Δ32/Δ32: Near-complete resistance to R5-tropic HIV-1 infection; frequency ~1% of Northern Europeans; the "Berlin patient" (Timothy Ray Brown) was cured of HIV by receiving a bone marrow transplant from a CCR5-Δ32/Δ32 donor
• Heterozygous CCR5-Δ32/+: Delayed HIV progression (~2–3 years slower to AIDS); ~10% frequency in Northern Europeans; gradient decreasing southward and eastward; essentially absent in sub-Saharan Africans, East Asians, and Indigenous Americans
• Historical selection: The high frequency of CCR5-Δ32 in Northern Europe (~10% heterozygote frequency) predates HIV; the allele must have conferred resistance to another pathogen — initially proposed as Yersinia pestis (bubonic plague) based on timing (allele rise coincident with Black Death ~1346 CE), but subsequent studies (Galvani & Slatkin, 2003) suggested smallpox (variola virus) as a more plausible agent; ancient DNA evidence is mixed; the true selective agent remains debated

2. CREDIBLE CLAIMS (Tier 2 — Strong Evidence, Active Research)

2.1 Black Death and Immune Gene Selection

• Klunk et al. (2022, Nature): Compared ancient DNA from individuals who died during the Black Death (~1346–1353 CE) with survivors — identified strong selection at immune loci, particularly: ERAP2 (endoplasmic reticulum aminopeptidase 2 — processes antigens for MHC-I presentation; protective allele conferred ~40% survival advantage), CTLA4 (immune checkpoint), TICAM2 (TLR signaling adaptor)
• These plague-selected alleles are now associated with increased risk for autoimmune diseases — Crohn's disease, rheumatoid arthritis — a potential trade-off between infection resistance and autoimmunity; "yesterday's resistance alleles are today's autoimmune risk variants"
• This represents the first direct ancient-DNA-based evidence for pathogen selection at specific loci with precisely dated timing

2.2 FUT2 and Norovirus

• FUT2 (secretor gene): Encodes α-1,2-fucosyltransferase; "secretors" (FUT2 functional) express ABO blood group antigens on mucosal surfaces and in secretions; "non-secretors" (homozygous loss-of-function, ~20% of Europeans) do not
• Non-secretors are strongly resistant to most norovirus strains — the virus uses cell-surface fucosylated glycans (particularly H type 1 antigen) as attachment factors; no receptor → no binding → no infection
• FUT2 polymorphism is maintained by balancing selection — secretor and non-secretor status confer resistance to different pathogens (norovirus vs. H. pylori, respectively)

2.3 Cystic Fibrosis Carrier Advantage Hypothesis

• CFTR ΔF508: The most common cystic fibrosis mutation; 1 in 25 Northern Europeans is a carrier; CF is lethal without treatment → the high carrier frequency suggests heterozygote advantage
• Proposed selective agents: cholera (reduced CFTR-mediated chloride secretion in heterozygotes → less fluid loss during cholera), typhoid fever (Salmonella typhi uses CFTR for cell entry — fewer receptors in carriers), or tuberculosis resistance; no consensus; mouse model evidence supports reduced susceptibility to S. typhi in CFTR heterozygotes (Pier et al., 1998)

3. SPECULATIVE CLAIMS (Tier 3 — Emerging / Theoretical)

3.1 Pathogen Pressure as Driver of Human Behavioral Evolution

• The "behavioral immune system" hypothesis proposes that disgust, xenophobia, and mating preferences evolved partly as parasite-avoidance mechanisms; populations with higher historical pathogen diversity show more collectivist cultural values and stricter social norms (Fincher & Thornhill, 2012); this remains highly debated — cultural and socioeconomic confounds are difficult to disentangle from genetic effects

3.2 Genome-Wide Pathogen-Driven Selection

• Fumagalli et al. (2011) estimated that ~7% of the genome shows signatures of pathogen-driven selection — making infectious disease the single largest category of selective pressure; top candidates include immunity genes (TLRs, cytokines, HLA), blood group antigens, and cell-surface receptors; the full landscape of resistance alleles is still being mapped

4. DUBIOUS CLAIMS (Tier 4 — Fringe / Unsubstantiated)

4.1 Disease Resistance as Evidence for "Racial" Superiority [UNFOUNDED]

• Claims that certain populations are "genetically superior" because they carry specific disease-resistance alleles are scientifically invalid — resistance alleles are adaptations to LOCAL pathogen pressures and carry fitness costs in other environments (sickle cell causes disease in homozygotes; plague-resistance alleles increase autoimmune risk); ALL human populations carry unique sets of adaptive variants reflecting their evolutionary histories; there is no gradient of "overall fitness" among populations

IMAGES

Counter-Arguments & Criticisms

No significant counter-arguments exist in the scholarly literature for the core claims presented here. The topic of Genetics Disease Resistance represents established knowledge within molecular biology and biochemistry with no active scholarly dispute over the fundamental claims presented in this document.

BIBLIOGRAPHY

1. Allison, A | 1954 | "Protection Afforded by Sickle-Cell Trait against Subtertian Malarial Infection" | BMJ | ∅ | ∅ | C. . , 1(4857), 290 294 | ∅ | doi:10.1136/bmj.1.4857.290 | ∅ | ∅ | ∅
2. Piel, F | 2010 | "Global Distribution of the Sickle Cell Gene and Geographical Confirmation of the Malaria Hypothesis" | Nature Communications | ∅ | ∅ | B. et al. . , 1, 104 | ∅ | doi:10.1038/ncomms1104 | ∅ | ∅ | ∅
3. Galvani, A | 2003 | "Evaluating Plague and Smallpox as Historical Selective Pressures for the CCR5-Δ32 HIV-Resistance Allele" | PNAS | ∅ | ∅ | P. & Slatkin, M. . , 100(25), 15276 15279 | ∅ | doi:10.1073/pnas.2435085100 | ∅ | ∅ | ∅
4. Klunk, J. et al. . , 611, 312 319 | 2022 | "Evolution of Immune Genes Is Associated with the Black Death" | Nature | ∅ | ∅ | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
5. Fumagalli, M. et al. . , 7(11), e1002355 | 2011 | "Signatures of Environmental Genetic Adaptation Pinpoint Pathogens as the Main Selective Pressure through Human Evolution" | PLoS Genetics | ∅ | ∅ | ∅ | ∅ | doi:10.1371/journal.pgen.1002355 | ∅ | ∅ | ∅
6. Ackerman, H. et al. . , 69(5), 559 565 | 2005 | "A Comparison of Case-Control and Family-Based Association Methods: The Example of Sickle-Cell and Malaria" | Annals of Human Genetics | ∅ | ∅ | ∅ | ∅ | doi:10.1111/j.1529-8817.2005.00180.x | ∅ | ∅ | ∅
7. Kwiatkowski, D | 2005 | "How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria" | American Journal of Human Genetics | ∅ | ∅ | P. . , 77(2), 171 192 | ∅ | ∅ | ∅ | ∅ | ∅
8. Pier, G | 1998 | "Salmonella typhi Uses CFTR to Enter Intestinal Epithelial Cells" | Nature | ∅ | ∅ | B. et al. . , 393, 79 82 | ∅ | ∅ | ∅ | ∅ | ∅
9. Karlsson, E | 2014 | "Natural Selection and Infectious Disease in Human Populations" | Nature Reviews Genetics | ∅ | ∅ | K., Kwiatkowski, D | ∅ | ∅ | ∅ | ∅ | P. & Sabeti, P; C. . , 15, 379 393
10. Dean, M. et al. . , 273(5283), 1856 1862 | 1996 | "Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene" | Science | ∅ | ∅ | ∅ | ∅ | ∅ | ∅ | ∅ | ∅

CROSS-REFERENCE INDEX

• Z_2_11 — Genetics of Immunity MHC Diversity: HLA polymorphism and pathogen-driven balancing selection
• Z_3_03 — Human Migration Genetics: Migration patterns and pathogen exposure zones
• L_2_02 — Population Genetics: Balancing selection and Hardy-Weinberg deviations
• ZB_2_01 — Natural Selection Evidence: Disease resistance as paradigm of natural selection
• Z_3_01 — Ancient DNA: Ancient DNA evidence for historical selection events
• Z_2_09 — Mitochondrial Genetics: Mitochondrial contributions to immune function

Last verified: Mar 07, 2026 — All sources peer-reviewed or from established human genetics and infectious disease literature